Skip to content
Axcess News – Lifestyle
Author:
20/20 Biolabs Inc.
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies
March 12, 2026
20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities
March 5, 2026
20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time
March 5, 2026
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol “AIDX” Following 3 Consecutive Years of Sales Growth
March 5, 2026
←
Previous Page
1
2